Related Experiment Video
Updated: Jan 4, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Modeling Parkinson's Disease Heterogeneity to Accelerate Precision Medicine
Gonzalo H Olivares1, Patricio Olguín1, Andrés D Klein2
1Program in Human Genetics, Institute of Biomedical Sciences, Biomedical Neuroscience Institute, Department of Neuroscience, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Abstract:
A mechanistic understanding of the diverse clinical manifestations of Parkinson's disease (PD) and variable patient response to treatments is lacking. Genetically diverse PD model organisms can be used to map modifier genes and understand clinically relevant phenotypes of varying severity. This strategy can accelerate the pace of discoveries for precision medicine purposes.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
EPS and iPS Cells in Disease Research
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

